Pro-BNP Level: A Diagnostic Biomarker for Heart Failure
Introduction to Pro-BNP
- Pro-BNP is a cardiac biomarker that serves as an essential diagnostic tool for heart failure, with levels directly related to left ventricular mass and inversely related to ejection fraction, making it valuable for both diagnosis and risk stratification 1
- Pro-BNP is formed as a pre-prohormone, which is split to form proBNP, and proBNP is further broken down to the active hormone BNP 1-32 and a breakdown product NT-pro-BNP 2
Types of Natriuretic Peptides
- Two main forms are measured clinically: BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro-B-type natriuretic peptide) 1
- BNP has a shorter half-life of approximately 20 minutes compared to NT-proBNP's half-life of 1-2 hours 1
- NT-proBNP has a wider detection range (0-35,000 pg/mL) and more stable structure compared to BNP (0-5,000 pg/mL) 3
Normal Reference Ranges
- Young adults have BNP levels < 25 pg/mL and NT-proBNP levels < 70 pg/mL 4
- Males aged 45-59 years have BNP levels < 100 pg/mL, and males > 60 years have BNP levels < 98 pg/mL 4
- Females aged 45-59 years have NT-proBNP levels < 164 pg/mL, and females > 60 years have NT-proBNP levels < 225 pg/mL 4
Diagnostic Cut-off Points for Heart Failure
- Exclusion of heart failure: BNP < 100 pg/mL (90% sensitivity, 76% specificity) 1
- Inclusion/diagnosis of heart failure: BNP > 400 pg/mL 1
- Exclusion of heart failure: NT-proBNP < 300 pg/mL (98% negative predictive value) 1, 5
- Inclusion/diagnosis of heart failure (age-dependent):
Clinical Significance and Interpretation
- Pro-BNP levels should be regarded as a continuous variable, with even mildly elevated levels associated with increased risk of death, heart failure, atrial fibrillation, and stroke 7
- For each 500 pg/mL NT-proBNP above baseline in patients with mild to moderate cardiac failure, there is an increased mortality risk of 3.8% 7
- The relative risk of death increases by 35% for each 100 pg/mL increase in BNP over a period of 1.5-3 years 7
Factors Affecting Pro-BNP Levels
- Gender: Males have consistently lower levels than females, likely due to androgen suppression of pro-BNP synthesis 4
- Body mass index: Higher BMI results in lower normal values of BNP 4
- Age: Levels increase with age 4
- Renal function: Decreased renal function can elevate levels, particularly NT-proBNP 1
Clinical Applications
- Diagnosis of heart failure in patients presenting with dyspnea 1
- Risk stratification in patients with confirmed heart failure 7
- Monitoring response to heart failure treatment (diuretics, ACE inhibitors, vasodilators) 7
- Prognostic indicator for mortality and cardiovascular events 6